微泰医疗器械（杭州）股份有限公司（股票代码：02235）于2026年3月4日发布截至2026年2月28日止月份的股份变动月报表。报告显示，公司法定注册股本为人民币421,078,000元，涵盖H股、内资股及非上市外资股三类股份。
其中，H股已发行数量由上月末的165,788,042股减少至165,586,942股，减少部分为2月内回购的201,100股H股，该等回购股份于月末均被持作库存股，库存在本月末增至3,588,900股。内资股及非上市外资股在本报告期内未发生变动，分别维持在208,205,474股及43,696,684股。
报告同时显示，公司于期内无新增发行股份，无可转债、权证及其他股份期权的变动信息。截至2026年2月28日，公司股本总数保持在169,175,842股H股、208,205,474股内资股及43,696,684股非上市外资股，整体股本结构保持稳定。公司声明已遵守香港联交所上市规则及相关法律法规。
公告由执行董事及联席公司秘书施永辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.